dc.contributor.author |
Peper, Janet Kerstin |
|
dc.contributor.author |
Bösmüller, Hans |
|
dc.contributor.author |
Schuster, Heiko |
|
dc.contributor.author |
Gückel, Brigitte |
|
dc.contributor.author |
Hörzer, Helen |
|
dc.contributor.author |
Röhle, Kevin |
|
dc.contributor.author |
Schäfer, Richard |
|
dc.contributor.author |
Wagner, Philipp Georg |
|
dc.contributor.author |
Rammensee, Hans-Georg |
|
dc.contributor.author |
Stevanović, Stefan |
|
dc.contributor.author |
Fend, Falko |
|
dc.contributor.author |
Staebler, Annette |
|
dc.date.accessioned |
2017-08-01T13:35:44Z |
|
dc.date.available |
2017-08-01T13:35:44Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
2162-402X |
|
dc.identifier.uri |
http://hdl.handle.net/10900/77322 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Taylor & Francis Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1080/2162402X.2015.1065369 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20160915142648_02051 |
|
utue.personen.roh |
Peper, Janet Kerstin |
|
utue.personen.roh |
Boesmueller, Hans-Christian |
|
utue.personen.roh |
Schuster, Heiko |
|
utue.personen.roh |
Gueckel, Brigitte |
|
utue.personen.roh |
Hoerzer, Helen |
|
utue.personen.roh |
Roehle, Kevin |
|
utue.personen.roh |
Schaefer, Richard |
|
utue.personen.roh |
Wagner, Philipp |
|
utue.personen.roh |
Rammensee, Hans-Georg |
|
utue.personen.roh |
Stevanovic, Stefan |
|
utue.personen.roh |
Fend, Falko |
|
utue.personen.roh |
Staebler, Annette |
|
dcterms.isPartOf.ZSTitelID |
Oncoimmunology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article e1065369 |
de_DE |
dcterms.isPartOf.ZS-Volume |
5 |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
|
utue.fakultaet |
04 Medizinische Fakultät |
|
utue.fakultaet |
Sonstige |
|